Healthtech Startups

Nordic Science Investments is an early-stage venture capital fund that invests in science-based startups and university spinouts across the Nordic region, with a focus on deeptech, health tech, and life sciences. The fund works with leading regional universities to commercialize frontier research and tackle global challenges.

1 investor

Nsight Health provides remote patient care using nursing staff and proprietary technology to monitor, predict, and prevent adverse health events, working through fee-for-service and at-risk contracts to lower care costs and improve outcomes. It serves patients across the United States, with a focus on underserved communities.

1 investor

Nucleo automates CT scan analysis for oncology care, providing AI-powered tools for tumor lesion sizing, body composition assessment, and lesion classification to support clinical workflows in hospitals.

1 investor

NucleoTech engineers BrainPortal carrier proteins that attach to therapeutic antibodies and oligonucleotides and transport them across the blood-brain barrier non-invasively, using a direct in vivo screening platform to test many candidates simultaneously. It advances internal CNS therapeutics and licenses its carriers to pharma and biotech partners.

1 investor

Nucleon Health provides a technology platform for healthcare financing and claims management, offering instant patient financing at discharge, automated claim submission and tracking, and immediate claim payments to hospitals. It serves hospitals, insurers, and patients, and states a network of 100+ hospitals across 8 regions.

1 investor

Nucleus RadioPharma develops and manufactures radiopharmaceutical products, with production facilities capable of scaling to hundreds of thousands of doses per year. It operates sites including a Minnesota location and Springhouse Innovation Park in Pennsylvania.

1 investor

Nudj Health provides interdisciplinary, whole-person care that combines lifestyle medicine and behavioral health to prevent and manage chronic disease. It serves patients, providers, employers, and payers through a virtual and in-person care delivery model focused on modifiable lifestyle behaviors.

1 investor

Next-gen mental wellness platform leveraging psychedelic-assisted therapies.

1 investor

Nueclear Healthcare Limited is a diagnostic network operating PET-CT centres across major Indian cities, offering advanced imaging technologies for cancer detection, staging, and monitoring. The company manufactures medical cyclotron units that produce radioactive biomarkers required for diagnostic scanning.

1 investor

NueHealth is a healthcare company focused on outpatient and ambulatory care facility development, operations, and payor strategy. This page lists its leadership team.

1 investor

Nuevométodo is an international digital health services provider that partners with insurance companies to integrate personalized wellness and mental health offerings into their policies. The company serves insurance carriers across Latin America, Spain, Portugal, and Puerto Rico.

1 investor

NuEyes develops smart glasses and digital loupes incorporating augmented reality and 3D stereoscopic vision technology for individuals with low vision and medical professionals. The company serves both the medical precision and consumer accessibility markets through wearable assistive technology.

1 investor

NuGen MD develops needle-free technologies and other medical delivery products for patients and practitioners. The company is pursuing regulatory approval in multiple countries.

1 investor

1 investor

Nui is a mobile app for family caregivers in Germany that provides information on care benefits, helps optimize care budgets, and assists with application processes for care support. The app connects users with care experts and is available free to members of select health insurance providers, with a paid tier for others.

1 investor

Nul offers science-based treatment to help people reduce or quit alcohol consumption, combining clinical prescribing, at-home liver function testing, and optional expert-led therapy. The service works with UK-based CQC-registered healthcare partners and is aimed at consumers seeking to change their drinking habits.

1 investor

NULASTIN is a beauty brand specializing in clinically formulated hair, lash, brow, and skin care products that use elastin replenishing technology. The company serves consumers seeking treatment solutions for hair loss and aesthetic concerns.

1 investor

Numb Corp develops TRPV1-targeted, botulinum-derived biologics that selectively enter sensory neurons to produce prolonged local inhibition of neurotransmission, aiming to deliver durable regional pain control. Its therapeutics are designed to be locally administered to control pain near its source while avoiding the systemic exposure associated with conventional pain medicines, including opioids.

1 investor

Numera manufactures personal emergency response and home safety devices, including wearable pendants, help buttons, and environmental sensors that integrate with the Libris system and Home Safety Hub for at-home monitoring and fall detection.

1 investor

Numiera is a biotech company developing new cancer therapeutics based on the study of tumor biology and cancer cell metabolism. It uses a preclinical platform to test novel therapies and aims to move basic research findings into oncology clinical trials.

1 investor

Nuna is a health technology company focused on healthcare data and analytics. Its leadership and board come from healthcare and technology backgrounds.

1 investor

Nuo Therapeutics is a commercial-stage medical device company developing biodynamic therapies for wound care. Its flagship product, Aurix, is a hematogel that uses a patient's own platelets and plasma to promote healing.

1 investor

NuPulse develops a cardiac support device used as a bridge to heart transplant, helping patients maintain mobility and improve their condition while awaiting a donor heart. Its technology is being evaluated through the NuPulse Voyage feasibility study.

1 investor

NuPulseCV develops the Voyage device, a cardiac support technology aimed at patients with heart failure who are treated at both major institutions and community hospitals. The company is guided by a scientific advisory board of clinically active cardiologists and cardiac surgeons.

1 investor